Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
LACK OF BENEFICIAL-EFFECTS OF L-ARGININE INFUSION IN PRIMARY PULMONARY-HYPERTENSION
Autore:
SURDACKI A; ZMUDKA K; BIERON K; KOSTKATRABKA E; DUBIEL JS; GRYGLEWSKI RJ;
Indirizzi:
JAGIELLONIAN UNIV,COLL MED,DEPT CARDIOL,17 KOPERNIKA PL-31501 KRAKOW POLAND JAGIELLONIAN UNIV,COLL MED,DEPT PHARMACOL PL-31007 KRAKOW POLAND
Titolo Testata:
Wiener Klinische Wochenschrift
fascicolo: 16, volume: 106, anno: 1994,
pagine: 521 - 526
SICI:
0043-5325(1994)106:16<521:LOBOLI>2.0.ZU;2-C
Fonte:
ISI
Lingua:
ENG
Soggetto:
NITRIC-OXIDE; RELAXING FACTOR; VASOCONSTRICTION; ACETYLCHOLINE; RESPONSIVENESS; PROSTACYCLIN; CIRCULATION; HYPOTENSION; EXCRETION; ARTERIES;
Keywords:
L-ARGININE; PRIMARY PULMONARY HYPERTENSION; HEMODYNAMICS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
36
Recensione:
Indirizzi per estratti:
Citazione:
A. Surdacki et al., "LACK OF BENEFICIAL-EFFECTS OF L-ARGININE INFUSION IN PRIMARY PULMONARY-HYPERTENSION", Wiener Klinische Wochenschrift, 106(16), 1994, pp. 521-526

Abstract

The aim of this study was to assess the effects of L-arginine in primary pulmonary hypertension (PPH). Diagnostic cardiac catheterization was performed in 4 patients (pts) (1 man and 3 women, aged 18-47 years)with suspected PPH. In all of them diagnosis of PPH was confirmed; mean pulmonary artery pressure (PAP) ranged from 46 to 83 mmHg. Then 61/min oxygen was administered for 10 min through the oxygen mask (first oxygen test). After another 15 min, L-arginine was infused into an antecubital vein at a dose of 12.63 g of L-arginine hydrochloride in 300 ml of 0.9% NaCl over 90 min. 15 min before the planned termination of the infusion the second oxygen test was performed in the same way as the first one. Hemodynamic data were collected by means of two catheters placed in the main pulmonary artery and in the aortic root. Cardiac output (CO) was estimated by the thermodilution technique. Blood samples were drawn from both catheters to estimate oxygen tension and cyclic GMP (cGMP) levels. In pts 1 and 2 differences between baseline values and following L-arginine did not exceed 9% for mean PAP (mPAP), total pulmonary resistance (TPR), mean aortic pressure (mAP), systemic resistance (SR), CO and HR. In patient 3 mAP and SR dropped by about 30%. In patient 4 after 15 min of the infusion mAP and SR fell by about 50%, whereupon we stopped L-arginine administration. Thus, for ethical reasons, we decided not to recruit new subjects for the study. In pts 1-3 aortic oxygen tension diminished by 10-15% on L-arginine. The response of mPAP and TPR to oxygen did not exceed 7%, being only slightly altered on L-arginine. Plasma cGMP in both aorta and pulmonary artery was not altered on L-arginine in pts 1-3. In patient 4 the set of data was incomplete due to the emergency caused by severe hypotension. It is concluded that L-arginine is ineffective in improving pulmonary hemodynamics in PPH. Moreover, the decrease in aortic oxygen content may be caused by L-arginine-induced flow redistribution towards potentiating the PPH-related ventilation/perfusion imbalance. Additionally, a risk of severe systemic hypotension is inherent in L-arginine infusion inPPH.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/09/20 alle ore 01:08:16